Home › Oramed Pharmaceuticals Moves Forward With Investigational New Drug Application For Oral Insulin
 

Keywords :   


Oramed Pharmaceuticals Moves Forward With Investigational New Drug Application For Oral Insulin

2013-02-27 01:19:04| drugdiscoveryonline News Articles

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been in communication with the U.S. Food and Drug Administration (FDA) regarding its Investigational New Drug (IND) application for oral insulin

Tags: application forward drug oral

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Teenagers could help fill train driver shortage
16.05Peak-time ScotRail fares scrapped for further three months
16.05Japanese brand to launch TVs 'Powered by TiVo'
16.05Disney and WBD announce Disney+, Hulu, Max bundle
16.05VIZIO reports Q1 2024 financial results
16.05Pixalate releases Q1 2024 CTV ad supply chain report
16.05'Time running out' plea over shipyard's future
16.05Eastern North Pacific Tropical Weather Outlook
More »